About Entegrion
Entegrion is a company based in Durham (United States) founded in 2002.. Entegrion has raised $30.45 million across 14 funding rounds from investors including ONR and U.S. Department of Defense. The company has 4 employees as of December 31, 2020. Entegrion offers products and services including VCM. Entegrion operates in a competitive market with competitors including Accriva Diagnostics, Diagnostica Stago, Enzyre, MedicQuant ApS and Perosphere, among others.
- Headquarter Durham, United States
- Employees 4 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Entegrion, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30.45 M (USD)
in 14 rounds
-
Latest Funding Round
$13.87 M (USD), Series B
Jul 05, 2022
-
Investors
ONR
& 1 more
-
Employee Count
4
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Entegrion
Entegrion offers a comprehensive portfolio of products and services, including VCM. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Portable system for rapid blood coagulation testing and hemostasis.
Unlock access to complete
Unlock access to complete
Funding Insights of Entegrion
Entegrion has successfully raised a total of $30.45M across 14 strategic funding rounds. The most recent funding activity was a Series B round of $13.87 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Series B — $13.9M
-
First Round
First Round
(08 Mar 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Series B - Entegrion | Valuation |
investors |
|
| May, 2019 | Amount | Series A - Entegrion | Valuation |
investors |
|
| Jul, 2012 | Amount | Grant - Entegrion | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Entegrion
Entegrion has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include ONR and U.S. Department of Defense. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Military forces are provided by the U.S. Department of Defense for national security.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Entegrion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Entegrion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Entegrion Comparisons
Competitors of Entegrion
Entegrion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accriva Diagnostics, Diagnostica Stago, Enzyre, MedicQuant ApS and Perosphere, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Near-patient diagnostic systems for coagulation testing are developed.
|
|
| domain | founded_year | HQ Location |
A portfolio of hemostasis and coagulation diagnostic products is manufactured.
|
|
| domain | founded_year | HQ Location |
Smart diagnostics devices for blood coagulation analysis are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostic kits for blood anticoagulant detection are provided.
|
|
| domain | founded_year | HQ Location |
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Entegrion
Frequently Asked Questions about Entegrion
When was Entegrion founded?
Entegrion was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Where is Entegrion located?
Entegrion is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Who is the current CEO of Entegrion?
John Mowell is the current CEO of Entegrion.
Is Entegrion a funded company?
Entegrion is a funded company, having raised a total of $30.45M across 14 funding rounds to date. The company's 1st funding round was a Grant of $1.9M, raised on Mar 08, 2007.
How many employees does Entegrion have?
As of Dec 31, 2020, the latest employee count at Entegrion is 4.
What does Entegrion do?
Entegrion was founded in 2002 in Durham, United States, and operates in the medical devices sector. Hemostasis and fluid replacement products are developed, including the Portable Coagulation Monitor based on Thromboelastography for emergency medicine, obstetrics, and surgery. Additional offerings encompass Multi-Functional Resuscitation Fluid, hemostatic patches, and Stasix particles for targeted vascular delivery. Operations focus on pre-hospital and clinical settings.
Who are the top competitors of Entegrion?
Entegrion's top competitors include Accriva Diagnostics, Diagnostica Stago and MedicQuant ApS.
What products or services does Entegrion offer?
Entegrion offers VCM.
Who are Entegrion's investors?
Entegrion has 2 investors. Key investors include ONR, and U.S. Department of Defense.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.